These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26272262)

  • 21. Anhedonia, self-experience in schizophrenia, and implications for treatment.
    Juckel G; Sass L; Heinz A
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S176-80. PubMed ID: 14677076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment.
    Millan MJ; Fone K; Steckler T; Horan WP
    Eur Neuropsychopharmacol; 2014 May; 24(5):645-92. PubMed ID: 24820238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making.
    Fervaha G; Graff-Guerrero A; Zakzanis KK; Foussias G; Agid O; Remington G
    J Psychiatr Res; 2013 Nov; 47(11):1590-6. PubMed ID: 23992770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anhedonia and motivational deficits in rats: impact of chronic social stress.
    Rygula R; Abumaria N; Flügge G; Fuchs E; Rüther E; Havemann-Reinecke U
    Behav Brain Res; 2005 Jul; 162(1):127-34. PubMed ID: 15922073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating negative-symptom-like behavioural changes in developmental models of schizophrenia.
    Moser P
    Eur Neuropsychopharmacol; 2014 May; 24(5):774-87. PubMed ID: 24332891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motivated to do well: an examination of the relationships between motivation, effort, and cognitive performance in schizophrenia.
    Foussias G; Siddiqui I; Fervaha G; Mann S; McDonald K; Agid O; Zakzanis KK; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):276-82. PubMed ID: 26008882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationships among cognition, motivation, and emotion in schizophrenia: how much and how little we know.
    Barch DM
    Schizophr Bull; 2005 Oct; 31(4):875-81. PubMed ID: 16079388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurobiological basis of motivational deficits in psychopathology.
    Salamone JD; Koychev I; Correa M; McGuire P
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1225-38. PubMed ID: 25435083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In support of Bleuler: objective evidence for increased affective ambivalence in schizophrenia based upon evocative testing.
    Trémeau F; Antonius D; Cacioppo JT; Ziwich R; Jalbrzikowski M; Saccente E; Silipo G; Butler P; Javitt D
    Schizophr Res; 2009 Feb; 107(2-3):223-31. PubMed ID: 18947981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wisket rat model of schizophrenia: Impaired motivation and, altered brain structure, but no anhedonia.
    Büki A; Bohár Z; Kekesi G; Vécsei L; Horvath G
    Physiol Behav; 2022 Feb; 244():113651. PubMed ID: 34800492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders.
    Foussias G; Agid O; Fervaha G; Remington G
    Eur Neuropsychopharmacol; 2014 May; 24(5):693-709. PubMed ID: 24275699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impramine, fluoxetine and clozapine differently affected reactivity to positive and negative stimuli in a model of motivational anhedonia in rats.
    Scheggi S; Pelliccia T; Ferrari A; De Montis MG; Gambarana C
    Neuroscience; 2015 Apr; 291():189-202. PubMed ID: 25686523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neural substrates underlying effort computation in schizophrenia.
    Fervaha G; Foussias G; Agid O; Remington G
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2649-65. PubMed ID: 24035741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An investigation into the drivers of avolition in schizophrenia.
    Suri G; Lavaysse LM; Young G; Moodie C; Tersakyan A; Gross JJ; Gard DE
    Psychiatry Res; 2018 Mar; 261():225-231. PubMed ID: 29329039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pick Your Model Wisely: Understanding the Negative Symptoms of Schizophrenia in Rodent Models.
    Yohn SE; Conn PJ
    ACS Chem Neurosci; 2019 Jan; 10(1):33-35. PubMed ID: 30346132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motivational deficits and cognitive test performance in schizophrenia.
    Fervaha G; Zakzanis KK; Foussias G; Graff-Guerrero A; Agid O; Remington G
    JAMA Psychiatry; 2014 Sep; 71(9):1058-65. PubMed ID: 25075930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct profiles of psychological and neuropsychological functions underlying goal-directed pursuit in schizophrenia.
    Gerritsen CJ; Goldberg JO; Kiang M; Remington G; Foussias G; Eastwood JD
    Aust N Z J Psychiatry; 2022 Dec; 56(12):1628-1641. PubMed ID: 35191327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model.
    Missault S; Van den Eynde K; Vanden Berghe W; Fransen E; Weeren A; Timmermans JP; Kumar-Singh S; Dedeurwaerdere S
    Brain Behav Immun; 2014 Nov; 42():138-46. PubMed ID: 24973728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits.
    Foussias G; Mann S; Zakzanis KK; van Reekum R; Agid O; Remington G
    Schizophr Res; 2011 Oct; 132(1):24-7. PubMed ID: 21771567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.